BTI gets financing, reduces net loss

Article

Magnetic source imaging developer Biomagnetic Technologies got some good news last month with word that it had secured a $1.5 million loan commitment from shareholder Dassesta International. BTI had been soliciting additional equity capital to stave off

Magnetic source imaging developer Biomagnetic Technologies got some good news last month with word that it had secured a $1.5 million loan commitment from shareholder Dassesta International. BTI had been soliciting additional equity capital to stave off a cash shortage (SCAN 1/21/98).

Further financing will be necessary, however. BTI is in the process of seeking additional equity capital from foreign investors to supplement the Dassesta loan, of which $895,000 has already been borrowed. Upon receipt of a minimum of $7 million of additional financing, BTI is obligated to repay the $1.5 million loan to Dassesta. Without additional financing in the near future, BTI will have difficulties operating as a going concern, according to the company.

In financial news, BTI reported fiscal second-quarter revenues of $1.7 million, up 11.6% compared with the $1.6 million reported in the same period last year. The firm’s net loss dropped to $597,000 for the period (end-March), compared with a net loss of $1.2 million in 1997.

BTI has also received an order for a Magnes 2500 Whole Head system from Tokyo Medical and Dental University in Japan, as well as acceptance of a system by the Institute pour la Recherche en Neurosciences et en Psychiatrie in Rouffach, France. The French site is employing the system for research on psychiatric patients, according to the company.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.